Companies / Assembly Biosciences, Inc.

Assembly Biosciences, Inc.

Nasdaq: ASMBCIK 1426800SOUTH SAN FRANCISCO, CA

Financials · FY2025

Revenue$72.30M
Net income$-6.12M
Total debt
Cash$32.29M
Diluted EPS$-0.55
Shares outstanding15.9M

Ownership

15.9M shares outstanding · as of May 1, 2026
1.5%Insiders
Ownership
Insiders1.47%234,124
Institutions92.21%14,654,296
Public float6.32%1,004,188

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Okazaki Jason ACEOCEO and President · Director
0.70%111,916
Delaney William E IVChief Scientific Officer
0.29%45,642
White Nicole SChief Manufacturing Officer
0.24%37,477
Gaggar AnujChief Medical Officer
0.18%28,000
0.07%11,089

Institutional holders 74

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 30, 2026Bjorkquist Jeanette M
Executive
SellCommon Stock$8.3K-312
-2.73%
11,105
0.07% of shares
low
Mar 30, 2026White Nicole S
Executive
SellCommon Stock$5.0K-188
-0.50%
37,486
0.24% of shares
low
Mar 30, 2026Bjorkquist Jeanette M
Executive
SellCommon Stock$440-16
-0.14%
11,089
0.07% of shares
low
Mar 30, 2026White Nicole S
Executive
SellCommon Stock$247-9
-0.02%
37,477
0.24% of shares
low
Mar 29, 2026Delaney William E IV
Executive
GrantCommon Stock$0+26K
+132.37%
45,642
0.29% of shares
low
Mar 29, 2026Okazaki Jason A
CEO
GrantCommon Stock$0+94K
+533.51%
111,916
0.70% of shares
low
Mar 29, 2026Bjorkquist Jeanette M
Executive
GrantCommon Stock$0+7K
+132.19%
11,417
0.07% of shares
low
Mar 29, 2026White Nicole S
Executive
GrantCommon Stock$0+26K
+222.72%
37,674
0.24% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Farallon Capital Partners, L.P.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ASMBCommon StockEquity045396207BBG000R62Q06